Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Esoterix

Esoterix is a leading laboratory services company focused on
high science, superior customer service, and innovative new products. With annual revenues in excess of $100 million and over 750 employees, Esoterix offers approximately 2,500 assays and profiles through its centers of excellence in the United States and Western Europe. Esoterix's extensive client base includes hospitals, physicians, pharmaceutical and biotechnology companies, reference laboratories, and managed care organizations.


Contact Details:
4590 Freidrich LaneBuilding 1, Suite 100
Austin
Texas
78744
United States of America
Tel:(800) 444-9111
Fax:(512) 225-1261
Email:aussmc@esoterix.com
WWW:

www.colorado-coag.com/




Loading...

Recent Publications by Esoterix:

The hemostatic system and malignancy.
There is an intimate relationship between the processes involved in...
27th February, 2009
Esoterix, Inc. Aurora, Colorado, USA. Clin Lymphoma Myeloma. 2008 Aug;8(4):230-6.
DOI Direct Link
Is there a genetic relationship between arterial and venous thrombosis?
There is an intimate relationship between the processes involved in...
13th February, 2008
Esoterix Coagulation, 8490 UplandDrive, Suite 100, Englewood, CO 80112, Clin Lab Sci. 2007 Fall;20(4):221-3.
A standardized ZAP-70 assay--lessons learned in the trenches.
BACKGROUND: The disease of chronic lymphocytic leukemia (CLL) has been...
7th December, 2007
Esoterix Center for Innovation, Brentwood, TN, USA Cytometry B Clin Cytom. 2006 Jul 15;70(4):276-83.
DOI Direct Link
Parenteral iron therapy is associated with a characteristic pattern of iron staining on bone marrow aspirate smears.
We developed anecdotal evidence that parenteral iron therapy is associated...
27th October, 2007
Esoterix Oncology, Brentwood, TN 37027, USA. Am J Clin Pathol. 2007 Oct;128(4):590-3.
DOI Direct Link
Diagnosing von Willebrand disease: a large reference laboratory's perspective.
Von Willebrand disease (vWD) is a common bleeding disorder. Diagnosis...
12th September, 2006
Esoterix, Inc., Semin Thromb Hemost. 2006 Jul;32(5):472-9.
DOI Direct Link

View more Esoterix research publications.

Press Releases on Esoterix:

BioPortfolio Logo
XIFIN Inc. Expands Its Molecular Diagnostics Industry Expertise 27th October, 2009 XIFIN, Inc.
SAN DIEGO, Oct. 27 /PRNewswire/ -- XIFIN(TM) Inc., the leading provider of revenue cycle management for diagnostic service providers, announced the addition of Rina Wolf as Vice President of
Axial Biotech Names New VP of Reimbursement and Regulatory Affairs 29th August, 2008 Axial Biotech, Inc.
SALT LAKE CITY, Aug. 29 /PRNewswire/ -- Axial Biotech, Inc., a company poised to revolutionize spine care through the development of molecular diagnostic and motion preserving technologies,
Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes 17th July, 2008 GlycoMark, Inc.
NEW YORK and WINSTON-SALEM, N.C., July 17 /PRNewswire/ -- Toyota Tsusho America, Inc. (New York, NY) and Nippon Kayaku Co., Ltd. (Tokyo, Japan) announced today the formation of a new joint venture
LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests 5th June, 2008 Vanda Pharmaceuticals Inc.
BURLINGTON, N.C. and ROCKVILLE, M.D., June 5 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), one of the world's leading clinical trials and

BioNews Results for Esoterix:

LabCorp is Scheduled to Present at the Credit Suisse 18th Annual Healthcare Conference
Yahoo! Canada:  Nov 6 2009 3:02PM Matching: esoterix

Esoterix Clinical Trials:

A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver

Esoterix Patents:

US Patent No.Title
7326577 Cell fixation and use in phospho-proteome screening
6994983 Kits for determination of thromboxane B.sub.2 metabolite and optimizing aspirin dosage
6967083 Thromboxane B2 metabolite methods for optimizing aspirin dosage
6905830 Tissue analysis and kits therefor

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 636 times since April 2007, the link to the organisation's website has been followed 67 times

Recent Search Terms used to find this page: esoterix | US Patent 7326577 | ESOTERIX COAG | esoterix laboratories description | esoterix in revenues | esoterix | Esoterix Aurora CO | esoterix laboratories | esoterix laboratories | Esoterix Inc. englewood | .

Search for more companies in Austin

Search for more companies in Texas



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Esoterix

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.